A open-label, single-sequence, 3-period, crossover study to evaluate the pharmacokinetic drug–drug interactions of drug when LCZ696 was coadministered with carvedilol in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Heart failure
- Focus Pharmacokinetics
- 11 Feb 2016 New trial record
- 01 Nov 2015 Results published in the Clinical Pharmacology in Drug Development.